| Nom |
entecavir |
| Nom anglais |
entecavir; 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one; 2-amino-9-[(3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-3,9-dihydro-6H-purin-6-one; 2-amino-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylidenecyclopentyl]-1,9-dihydro-6H-purin-6-one hydrate (1:1); entecavir Baraclude |
| Formule moléculaire |
C12H15N5O3 |
| Poids Moléculaire |
277.2792 |
| InChI |
InChI=1/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8+/m0/s1 |
| Numéro de registre CAS |
142217-69-4;1367369-76-3 |
| Structure moléculaire |
|
| Indice de réfraction |
1.837 |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
FR
CN
CZ
DE
EN
ES
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
